Stay updated on Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.

Latest updates to the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page
- Check3 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page previously showed a 403 error; the HTML for that error page and the Home link were removed, yielding a standard layout for the page.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page now renders a 403 Forbidden error page in place of the study record, with a minimal header and a 403 message. This replaces the expected study details, documents, and location content, indicating access is blocked.SummaryDifference18%

- Check38 days agoChange DetectedThe study's list of participating sites was updated to include Tel Litwinsky, Israel and remove Qiryat Krinitzi, Israel.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Qiryat Krinitzi, Israel as a study site and removed Tel Litwinsky, Israel from the locations. The page revision updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

Stay in the know with updates to Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.